about
Key Residues Controlling Phenacetin Metabolism by Human Cytochrome P450 2A EnzymesComputed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trialAdaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous systemSimultaneous interstitial pneumonitis and cardiomyopathy induced by venlafaxine.The inhaled glucocorticoid fluticasone propionate efficiently inactivates cytochrome P450 3A5, a predominant lung P450 enzyme.Ethanol-mediated regulation of cytochrome P450 2A6 expression in monocytes: role of oxidative stress-mediated PKC/MEK/Nrf2 pathway.Pharmacokinetics of loxapine following inhalation of a thermally generated aerosol in healthy volunteers.Comparative pathobiology of environmentally induced lung cancers in humans and rodents.Identification of amino acid determinants in CYP4B1 for optimal catalytic processing of 4-ipomeanol.Impact Assessment of Cigarette Smoke Exposure on Organotypic Bronchial Epithelial Tissue Cultures: A Comparison of Mono-Culture and Coculture Model Containing Fibroblasts.Glutathione S-transferase copy number variation alters lung gene expression.Evaluation of inhibition selectivity for human cytochrome P450 2A enzymesHuman cyt P450 mediated metabolic toxicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) evaluated using electrochemiluminescent arrays.Effects of CYP3A5 genetic polymorphism and smoking on the prognosis of non-small-cell lung cancer.Human cytochrome p450 family 4 enzymes: function, genetic variation and regulation.Modulation of lung molecular biomarkers by beta-carotene in the Physicians' Health Study.Screening for Chemical Toxicity Using Cryopreserved Precision Cut Lung Slices.Multiple dose pharmacokinetics of inhaled loxapine in subjects on chronic, stable antipsychotic regimens.ABC transporters in Saccharomyces cerevisiae and their interactors: new technology advances the biology of the ABCC (MRP) subfamily.Chronic obstructive pulmonary disease and lung cancer: new molecular insights.Extrahepatic metabolism at the body's internal-external interfaces.DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences.Construction of a computable network model for DNA damage, autophagy, cell death, and senescence.Generation of tailored aerosols for inhalative drug delivery employing recent vibrating-mesh nebulizer systems.Pharmacokinetic evaluation of tissue distribution of pirfenidone and its metabolites for idiopathic pulmonary fibrosis therapy.Xenobiotic metabolism in differentiated human bronchial epithelial cells.Genetic variation of genes for xenobiotic-metabolizing enzymes and risk of bronchial asthma: the importance of gene-gene and gene-environment interactions for disease susceptibility.Identification of cytochrome P450 monooxygenase genes from the white-rot fungus Phlebia brevispora.Gene expression analysis of membrane transporters and drug-metabolizing enzymes in the lung of healthy and COPD subjects.Inhibition of the enzyme activity of cytochrome P450 1A1, 1A2 and 3A4 by fucoxanthin, a marine carotenoid.Ligand characterization of CYP4B1 isoforms modified for high-level expression in Escherichia coli and HepG2 cells.Metabolite profiling and enzyme reaction phenotyping of luseogliflozin, a sodium-glucose cotransporter 2 inhibitor, in humans.Extrahepatic Drug-Metabolizing Enzymes and Their SignificanceImportance of the Keap1-Nrf2 pathway in NSCLC: Is it a possible biomarker?
P2860
Q27652043-73BCF98C-FD32-46E3-8DF9-8AFF989A6C22Q28285393-560E17F7-0D50-4ACC-82FF-FDF63DE0538CQ28389419-C7538E8D-0488-4BF4-8F4C-653409071E14Q33942956-7D59F358-71A6-431E-91A7-445DDB0BA33AQ34076521-88FCA46C-D05A-4242-AD21-0B208D1D90F8Q34243809-C0F39F96-5368-4B9F-B9E2-6AA9D695D9ADQ34613851-A042E55E-6167-480E-A29E-18644CA27A14Q35027707-DA3D5D16-D254-4479-837A-AB5852D47E98Q35032512-4505AD0C-0FAA-4B86-8208-06F4E4A62983Q35995917-E126EC43-9F66-4F4F-84E4-F156133205E5Q36101789-2586E4CC-B516-4794-A3FB-5FF0B3341519Q36174285-DD88734E-9824-4D22-944D-811AC9E126C3Q36347374-419BEC86-AA1F-4219-B605-94878896A830Q36702536-526A834B-E8E9-4124-A543-A4B634EF049AQ36929610-0E877647-0E2B-48BB-A33A-1972F5619E66Q37114279-A8D48C1B-4552-4B9D-8E43-4D9EFF0AA40FQ37228595-49DC4518-517A-4982-938A-ECB543F3B32BQ37268835-A63F0C36-A444-476A-B21C-D4412A3DC256Q37451526-0B70AFB5-5493-4426-802F-A73AD43DF3CCQ37856648-F7A5616C-805F-4F7C-BD1D-81B2BC52694FQ38199198-F10CF751-E009-4E76-A0F6-C315CBA48026Q38315516-0403963E-8386-453E-AC12-8D526700374DQ38454300-11160CB8-D2FB-48D6-AF4A-37BDDF45DD41Q38498038-BF6FE59C-557D-4F6B-9EE8-15B5C6EAB293Q38930874-CC661940-A98B-44CE-8E4F-A9E18CA5FFE0Q39293415-6512AF71-EF7F-4D72-BBB8-E38F7859DC16Q39965794-53D3BF6B-95A6-4E7E-A06C-46422769EE47Q42073839-A921E86E-070F-4215-8FDA-AA7031F28C93Q42930859-C8F4A2A8-F9EC-421A-9C2C-5B4F03FA4A82Q42959433-B7CCF909-DDD6-4429-BA42-390A3F914667Q47996008-EED0FEE9-033A-47FD-91A6-909AB694BE2BQ51679305-B25557DE-93AC-435F-BDE0-6A044B0BA819Q57258718-ADB0F4D4-B872-4508-B467-F306C029D206Q57786820-1CC18052-7EB4-4CB6-8B6A-FF2C639A763C
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Xenobiotic-metabolizing enzymes in human lung.
@ast
Xenobiotic-metabolizing enzymes in human lung.
@en
type
label
Xenobiotic-metabolizing enzymes in human lung.
@ast
Xenobiotic-metabolizing enzymes in human lung.
@en
prefLabel
Xenobiotic-metabolizing enzymes in human lung.
@ast
Xenobiotic-metabolizing enzymes in human lung.
@en
P2093
P1476
Xenobiotic-metabolizing enzymes in human lung.
@en
P2093
Chandra Prakash
Ji Y Zhang
Yuefen Wang
P304
P356
10.2174/138920006779010575
P407
P577
2006-12-01T00:00:00Z